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Abstract
Introduction:  The purpose of this study is to determine how the histological subtypes of renal cell carcinoma
(RCC) vary among the heterogeneous Singaporean population and how this affects the survival rate.
Patients  and  methods:  The data analyzed in this retrospective study of the histological subtypes of RCC
cases treated in Singapore General Hospital over a ten year period (2001–2010) were obtained from the
Cancer Registry of the hospital’s department of urology. Statistical analysis was done using the Statistical
Package Service Solution (SPSS) version 17.0 software. Chi Square and z-tests were used where appropriate;
a p  value <0.05 was considered significant.
Results:  The records of 676 patients studied showed that 80.8% of the patients were Chinese, while Malays,
Indians and other minor groups accounted for 6.5%, 4.6% and 8.1%, respectively. The mean age (SD) at
presentation was 58.1 (12.1), 57.6 (10) and 55.1 (9.6) years for the Chinese, Indians and Malays, respectively.
The commonest histological variant in each of the ethnic groups, irrespective of sex, was clear cell carcinoma
which accounted for 79.7% of all the histological subtypes found in Chinese, for 70.5% in Malaysian and
77.4% in Indian patients. The sarcomatoid histological subtype was found in 4.3% of the studied population
with a high prevalence in the Indian ethnicity (9.7%). The worst survival rate (33.3%) was recorded among
Malays with the papillary cell subtype, and also in the Chinese population the highest mortality rate was
found in cases with the papillary cell subtype (16.9%).
Conclusion:  The commonest histological subtype of RCC in each of the studied ethnic groups in Singapore
is clear cell carcinoma. However, most of the cancer deaths in Chinese (16.9%) and Malays (66.7%)Abbreviations: RCC, renal cell carcinoma; Std, starndard.
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were associated with the papillary cell type, while in Indians the sarcomatoid component prevailed (9.7%).
Thus, the usual prognostic trend for RCC subtypes cannot be applied to all Singaporean ethnicities,
necessitating individualization of prognosis for each group.
© 2014 Pan African Urological Surgeons’ Association. Production and hosting by Elsevier B.V. 
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The incidence of renal cell carcinoma (RCC) varies across various
geo-ethnic groups worldwide. RCC is the 13th most common malig-
nancy worldwide, with approximately 271,000 new cases diagnosed
in 2008 [1]. The highest incidence is found in Europe, North Amer-
ica, and Australia, whereas it is low in India, Japan, Africa, and
China. In the United States, RCC accounts for 2–3% of all adult
malignant neoplasms [1,2] and is the most lethal of all urologic can-
cers [2]. Incidence rates are 10–20% higher in African Americans
for unknown reasons [2].
The Czech Republic has the highest age-standardised rate for
RCC in Europe. This has been estimated to be 33.6 and 15.0 per
100,000/year for males and females, respectively [3]. Other Euro-
pean countries that have been documented to have high incidence
rates include Lithuania, Latvia, Estonia, and Iceland, while the
incidence is lowest in Romania, Cyprus, and Portugal [3]. The age-
standardised rates for Singaporean males and females are 5.4 and
2.9 per 100,000/year [4], respectively. RCC typically occurs in the
fifth to seventh decade of life and is more common in the Chinese
population compared to Indians and Malays [4].
The histological variants of RCC differ in prognostic significance
with the sarcomatoid variant signifying an especially poor progno-
sis [5,6] when present in any of the histological subtypes. These
histological subtypes have also been shown to vary across different
ethnic groups. Young African Americans with sickle cell traits have
been found to rather have the medullary type of RCC [7,8]. Papillary
RCC has also been shown to be commoner among the black com-
pared to the white population in the United States [9]. In Malaysia,
a neighboring country to Singapore, a ten-year review of the clin-
ical characteristics of RCC revealed that the clear cell histological
subtype was the commonest (75.1%) among the ethnic groups stud-
ied [10]. The sarcomatoid variant was also found to be commoner
(2.7%) when compared with earlier studies in the region.
The aim of this study is to assess how the histological subtypes of
RCC vary in each of the ethnic groups in Singapore, as these sub-
types have been shown to contribute to the outcome of the disease.
Patients  and  methods
This is a retrospective study of the histological subtypes of RCC
cases treated in Singapore General Hospital (SGH) over a ten-
year period (2001–2010). The data and permission for the study
were obtained from the Singhealth Centralized Institutional Review
Board (CIRB, Ref: 2009/1053/D). The content of the data obtained
included the ethnicity categorized as Chinese, Malays, Indians and
others (Indonesians, Vietnamese and other minor groups). Other
data collected included age, gender and the histological subtype
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tategorized as clear cell, papillary, chromophobe, collecting duct
nd unclassified subtypes. The mean follow-up period and survival
utcome were also recorded. Tumor staging was based on the widely
ccepted 2002 TNM classification. The data were analyzed using
he Statistical Package Service Solution (SPSS) software version
7.0. Chi Square and z-tests were used where appropriate; a p value
0.05 was considered significant.
esults
he total number of patients diagnosed with RCC between 2001
nd 2010 was 752. Out of these, 76 patients did not have any or
ad no complete histopathological report and were excluded from
he study, thus leaving a total number of 676 patients. The Chinese
ccounted for 80.8% and the Malays for 6.5%, while the percent-
ge of the Indians and other minor groups studied was 4.6% and
.1%, respectively. The mean age (SD) at presentation was 58.1
12.1), 57.6 (10) and 55.1 (9.6) years for the Chinese, Indians and
alays, respectively. The male to female ratio was 2:1 in the general
opulation.
he results of the study also revealed that the commonest histolog-
cal variant in each of the ethnic groups, irrespective of sex, was
lear cell carcinoma. It accounted for 79.7% of all the histological
ubtypes found among the Chinese, for 70.5% in the Malays, for
7.4% in the Indians and for 70.9% in the other ethnicities stud-
ed (Table 1). This was followed by papillary carcinoma (11.9%) in
he Chinese population and papillary carcinoma in conjunction with
nclassified subtypes in the Indians (9.8% each). For the Malays and
he other ethnic minorities in Singapore the unclassified histological
ubtype represented the second most common category (Table 1).
he sarcomatoid histological subtype was found in 29 patients
4.3%) with RCC, with the highest prevalence found in the Chinese
n = 20; 68.9%). The majority of the sarcomatoid variants (n  = 16;
5.1%) was associated with the clear cell subtype (Table 2). All the
tudied ethnic groups mainly presented with stage-I disease which
ccounted for 77.4%, 63.6% and 59.2% of all cases in the Indians,
alays and Chinese, respectively. The second most predominant
tage was stage II (18.5%) in the Chinese, stage III (18.2%) in the
alays and stage IV (12.9%) in the Indians. The mean follow-up
eriod was 3 years, with a maximum duration of 10.3 and a median
uration of 2.3 years. The overall mortality rate was highest (24%) in
he Malays, while the mortality rates in the Indians and the Chinese
ccounted for 19.4% and 19.5%, respectively. Most of the deaths
68%) recorded among those with complete records (18.5%) were
ttributed to RCC. The cancer-specific death rate was 70% for the
alays, 64.1% for the Chinese and 33.3% for the Indians.
hen cancer specific deaths within the ethnic groups were dis-
ributed according to the disease stage, more Chinese (45.4%) and
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Table  1  Distribution of histological subtypes according to ethnicity.
Subtype Chinese Malays Indians Others
Clear cell 435 (79.7%) 31 (70.5%) 24 (77.4%) 39 (70.9%)
Papillary 65 (11.9%) 5 (11.4%) 3 (9.8%) 6 (10.9%)
Chromophobe 17 (3.1%) 1 (2.3%) 1 (3.2%) 2 (3.6%)
Collecting duct 1 (0.2%) 0 0 0
Unclassified 28 (5.1%) 7 (15.8%) 3 (9.8%) 8 (14.5%)
Total 546 (100%) 44 (100%) 31 (100%) 55 (100%)
Table  2  Cross tabulation of the histological subtypes with ethnicity and sarcomatoid component.
Histological subtype Sarcomatoid component
Chinese Malays Indians Others Total
Clear cell 11 2 0 3 16
Papillary 1 0 0 0 1
Chromophobe 0 0 1 0 1
Collecting duct 0 0 0 0 0
Unclassified 8 0 2 1 11
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ndians (50%) were found to have died from stage IV disease, while
ost Malays (57.1%) died from stage III disease. Cross-tabulation
f the histological subtype with cancer-specific death (Table 3)
evealed that the highest cancer-specific death among the Chinese
s well as the Malays was associated with the papillary subtype
N = 11; 16.9% and N  = 4; 66.7%, respectively). The histological
ubtype associated with the highest percentage of cancer deaths
mong the Indians is the chromophobe subtype (N  = 1; 100%). The
orst survival rate for renal cell carcinoma recorded in the Indians
0%) and Malays (33.3%) was due to the chromophobe and papillary
ell subtypes, respectively. The worst survival rate in the Chinese
as also found with the papillary subtype (83.1%) (Table 4).
iscussionhe prognosis of RCC has improved over the past few decades,
artly due to a shift in the stage of presentation to the left as a result
f radiologic screening and improvement in treatment modalities.
istological variants of RCC in conjunction with grade and stage are
s
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Table  3  Cross-tabulation of ethnicity with histological subtype and canc
Ethnicity Clear cell Papillary Ch
Chinese 53 (12.1%) 11 (16.9%) 1 (
Malays 2 (6.7%) 4 (66.7%) 0 
Indians 0 0 1 (
Others 1 (2.6%) 0 0 
Table  4  Cross-tabulation of ethnicity with histological subtype and surv
Ethnicity Survival rate (%)
Clear cell Papillary cell C
Chinese 87.9 83.1 
Indian 100.0 100.0 
Malay 93.3 33.3 1
Others 97.4 100.0 13 4 29
ery crucial in the determination of the management and outcome
f this disease [5,6]. Studies on the role of race in the distribution
f the histological variants of RCC are scarce. The results of this
tudy revealed that the mean age (years) at presentation for the
hinese (58.2) and Indians (57.6) was a little higher than that for
he Malays (55.1 years). This is contrary to an earlier report on
 similar population which showed that the Malays had a more
dvanced age at presentation compared to the Indians and Chinese
10]. This trend may be due to a disparity in the population size of
ach of the ethnic groups included in the studies in question; while
he Malays constituted a high proportion of the population in the
ormer study, the Chinese constituted the largest percentage in the
urrent study.
he interpretation of survival data depending on the different RCC
ubtypes is controversial, but many studies suggest that chromo-
hobe RCC has a significantly better prognosis than clear cell and
apillary RCC, which have an intermediate prognosis [6,11]. Col-
ecting duct carcinoma, reported in less than 1% of RCC, generally is
er specific death.
romophobe Collecting duct Unclassified
6.3%) 0 9 (9.8%)
0 4 (44.4%)
100%) 0 1 (20%)
0 0
ival rate.
hromophobe Collecting duct Unclassified
93.7 100 90.2
0.0 – 80.0
00.0 – 55.6
00.0 – 100.0
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an aggressive RCC type that tends to progress early with metastatic
disease and is associated with a short survival time [12].
The results of our study show that the clear cell variant accounted
for 78.3% of all the cases of RCC in the general population. This
is in keeping with the 70–80% prevalence documented in an ear-
lier study among the Western population by Störkel et al. [5] and
also by Singam et al. (75.1%) in his ten-year review of the clinical
characteristics of RCC among the Malaysian population [10].
The second and third predominant variants of RCC documented
in the literature are the papillary (10–15%) and the chromophobe
variants (1–5%) [7]. This trend was seen among the Chinese and
the Indians. However, the unclassified subtypes were the second
commonest in the Malays which is not in keeping with the said
trend.
Sarcomatoid RCC, when present, is an uncommon but particularly
aggressive component of RCC, accounting for 1– 5% of all renal
malignant neoplasms [14–16]. It can occur in any of the histolog-
ical subtypes of RCC [7] and its presence represents an ominous
prognostic factor [17]. In this study, sarcomatoid histology was pre-
dominantly found in patients with clear cell carcinoma in all ethnic
groups, which is in keeping with findings of other studies [13].
The sarcomatoid variant was found in 4.3% of the general population
studied, which is higher than the value (2.7%) documented in a
study by Singam et al. [10] involving a similar group
.
This may
imply that the general Singaporean population with RCC is likely
to have a worse outcome than their Malaysian counterparts, since
the proportion of those with the sarcomatoid component amongst
them is higher. Indians were found to have the highest percentage
(9.7%) of the sarcomatoid variant when individual ethnicity was
considered; this may be the reason why they presented with a more
advanced stage of RCC (stage IV). However, the low number of
Indians involved in this study precludes any significant association
between them and this finding.
Cancer-specific deaths were found to be higher in Malays com-
pared to Indians and Chinese, with more deaths occurring among
Malays and Chinese with the papillary subtype and Indians with
the chromophobe subtype. This finding related to the Malays and
Chinese is contrary to that of a study in Americans where more
deaths were recorded among patients with the clear cell and chro-
mophobe subtype than with the papillary subtype [5]. The Chinese
and the Malays are likely to survive less when the papillary variant
is present, while the Indians survived less with the chromophobe
variant (Table 4). These findings suggest that the expected trend is
not applicable to all the ethnicities found in Singapore with regard to
the prognosis based on subtypes. For example, the subtype usually
considered favorable (chromophobe) was associated with an unfa-
vorable outcome (higher mortality) in the Indian population. Also,
Malays and Chinese with the papillary subtype are likely to have
a bad outcome from RCC, hence necessitating closer surveillance
and more rigorous intervention for this category of patients.
In conclusion, the commonest histological subtype of RCC in each
of the studied ethnic groups in Singapore is the clear cell histologi-
cal subtype. Taking into consideration the histological subtype, most
cancer deaths in Chinese (16.9%) and Malays (66.7%) were asso-
ciated with the papillary subtype, while the Indians had the highest
sarcomatoid component (9.7%). Thus, the usual prognostic trend
[187
sing RCC subtypes is not the same among all Singaporean ethnic-
ties, thereby suggesting an individual prognosis for each group.
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